Sarah B. Noonberg Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah B. Noonberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah B. Noonberg. Sarah B. Noonberg is a Director in Protagonist Therapeutics, Inc ($PTGX) and a Director in Neoleukin Therapeutics, Inc. ($AQXP) and a Chief Medical Officer in Prothena Corp plc ($PRTA).
Address: C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which Sarah B. Noonberg is an Insider
Neoleukin Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah B. Noonberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protagonist Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah B. Noonberg: Director
Holdings: 4,700 shares
Current Value: $84,130
Latest Transaction: Feb 12 2021
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PROTHENA CORP PUBLIC LTD CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah B. Noonberg: Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 18 2017
$PRTA Market Capitalization: $1.71B
$PRTA Previous Close: $49.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sarah B. Noonberg
Sentiment: All, NLTX, PTGX, PRTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | NLTX | Neoleukin Therapeu ... | Noonberg Sarah B. | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 3,700 | 25,826 | 3,600 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 4,700 | 32,806 | 7,300 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 25.09 | 3,700 | 92,833 | 0 | 3.7 K to 0 (-100.00 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Grant | A | 6.98 | 3,700 | 25,826 | 3,700 | 0 to 3.7 K |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 26.04 | 400 | 10,416 | 0 | 400 to 0 (-100.00 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 25.42 | 4,300 | 109,306 | 400 | 4.7 K to 400 (-91.49 %) |